Rhode Island
$315 Million Résumé Check: CVS Settles Federal Opioid-Dispensing Case Covering Foulkes’s Four Years Running Its Pharmacies
What happened
Woonsocket-based CVS Pharmacy Inc. and related entities have agreed to pay $315 million to resolve a federal case alleging that, from Oct. 17, 2013 through Dec. 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act, then billed many of those invalid prescriptions to Medicare and other federal health programs in violation of the False Claims Act. The Justice Department announced the deal on Tuesday, Oct. 13.
The government’s complaint, filed Dec. 13, 2024 in U.S. District Court in Providence, alleged CVS filled excessive opioid quantities, early refills and dangerous “trinity” combinations (an opioid, a benzodiazepine and a muscle relaxant), including from “pill mill” prescribers, despite clear red flags. It said the violations stemmed from corporate-imposed performance metrics, incentive pay and staffing policies that put profits over patient safety, left too few pharmacists on duty, and kept pharmacists from warning one another about problem prescribers. The case began as a whistleblower suit by former CVS employee Hillary Estright. Besides the payment, CVS signed an agreement with the DEA to set up a tip hotline, monitor dispensing patterns and vet suspect prescribers.
CVS told the AP it strongly disagrees with the claims and that the settlement admits no wrongdoing. The Justice Department’s own release notes the claims “are allegations only and there has been no determination of liability.”
Original reporting
Read the underlying sources:
Virtue Forge commentary
Helena Foulkes is running for governor largely on her résumé: the seasoned executive who will bring private-sector competence to a state government that badly needs it. That is a fair pitch, and Rhode Island could use more leaders who have actually run something. But a résumé is a record, and records get checked. This week the federal government secured a $315 million settlement from the company she helped lead, over conduct that runs straight through the years she ran its drugstores.
Free enterprise is not a defense here. It is the reason this matters. Markets work because companies are held to the law, and taxpayers should never be billed for prescriptions that never should have been filled. The government’s core allegation, that pharmacy metrics and thin staffing pushed pharmacists to fill first and ask questions later, is a management-systems charge, the exact territory a retail-division president is responsible for. Voters are entitled to hear Foulkes explain in detail which of those policies she inherited, which she set, and which she changed. A spokesperson’s paragraph is not that.
Note the settlement also resolves alleged conduct running years after she left in 2018, so this is not a verdict on one executive. And CVS admitted nothing. That cuts both ways: the company avoided a trial, and voters lost the chance to see the evidence tested. The candidate who says she can fix Smith Hill should be the first to want that record fully aired.
What to watch: whether Foulkes answers specific questions about CVS staffing and dispensing policy before Nov. 3, how much of the $315 million reaches Rhode Island, and whether Republican Ken Block makes the record an issue in the final debates.